![]() Ardelyx Ardelyx develops novel oral therapeutics to treat mineral metabolism and metabolic disorders. | ||
Founding Date | Founding Date 2007 | Founding Date 1895 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Fremont, US HQ Waltham, US Waltham, US | Locations Bad Vilbel, DE HQ Beijing, CN Hangzhou Shi, CN Shanghai, CN Bad Vilbel, DE Budapest, HU Vilnius, LT see more |
Employees | Employees 882% increase | Employees 12,33911% increase |
Valuation ($) | Valuation ($) 1.4 b | Valuation ($) 6 b |
Financial | ||
Revenue (est.) | Revenue (est.) $407.3m (FY, 2025) | Revenue (est.) €3b (FY, 2020) |
Cost of goods | Cost of goods $39.5m (FY, 2025) | Cost of goods €1.3b (FY, 2020) |
Gross profit | Gross profit $367.8m (FY, 2025) | Gross profit €1.7b (FY, 2020) |
Net income | Net income ($61.6m) (FY, 2025) | Net income €181.9m (FY, 2020) |

STADA Arzneimittel is a company engaged in the healthcare and pharmaceuticals business.
View company